![Approaches for half-life extension of GLP-1 agonists. (a) Liraglutide... | Download Scientific Diagram Approaches for half-life extension of GLP-1 agonists. (a) Liraglutide... | Download Scientific Diagram](https://www.researchgate.net/profile/Martin-Lorenz/publication/237069612/figure/fig1/AS:601682660577283@1520463733155/Approaches-for-half-life-extension-of-GLP-1-agonists-a-Liraglutide-and-semaglutide_Q640.jpg)
Approaches for half-life extension of GLP-1 agonists. (a) Liraglutide... | Download Scientific Diagram
![The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release - ScienceDirect The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221112471930899X-fx1.jpg)
The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release - ScienceDirect
![Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41581-020-00367-2/MediaObjects/41581_2020_367_Fig1_HTML.png)
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology
![Dipeptidyl Peptidase-4 Inhibitor Glucagon-like Peptide-1 Receptor Agonist Liraglutide Dulaglutide PNG, Clipart, Analog, Angle, Dipeptidyl Peptidase-4 Inhibitor Glucagon-like Peptide-1 Receptor Agonist Liraglutide Dulaglutide PNG, Clipart, Analog, Angle,](https://cdn.imgbin.com/3/15/21/imgbin-dipeptidyl-peptidase-4-inhibitor-glucagon-like-peptide-1-receptor-agonist-liraglutide-dulaglutide-others-UvMTKAUcvX7bwZeG6QiCGhhxn.jpg)
Dipeptidyl Peptidase-4 Inhibitor Glucagon-like Peptide-1 Receptor Agonist Liraglutide Dulaglutide PNG, Clipart, Analog, Angle,
![Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing](https://w7.pngwing.com/pngs/475/613/png-transparent-dipeptidyl-peptidase-4-inhibitor-glucagon-like-peptide-1-receptor-agonist-liraglutide-dulaglutide-others-angle-text-pharmaceutical-drug-thumbnail.png)
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
![Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics. - Abstract - Europe PMC Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4875959/bin/40262_2015_343_Fig1_HTML.jpg)
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics. - Abstract - Europe PMC
![Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK279141/bin/pharmaco-agent-diab2-Image007.jpg)
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
![A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity | SpringerLink A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40200-020-00619-9/MediaObjects/40200_2020_619_Fig1_HTML.png)
A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity | SpringerLink
![Short‐acting glucagon‐like peptide‐1 receptor agonists as add‐on to insulin therapy in type 1 diabetes: A review - Albèr - 2017 - Diabetes, Obesity and Metabolism - Wiley Online Library Short‐acting glucagon‐like peptide‐1 receptor agonists as add‐on to insulin therapy in type 1 diabetes: A review - Albèr - 2017 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/4e7d7e1a-ce9f-4f89-91cd-840a1fd9735b/dom12911-fig-0001-m.jpg)
Short‐acting glucagon‐like peptide‐1 receptor agonists as add‐on to insulin therapy in type 1 diabetes: A review - Albèr - 2017 - Diabetes, Obesity and Metabolism - Wiley Online Library
Glucagon-like peptide-1 analogues for type 2 diabetes mellitus: current and emerging agents - Document - Gale Academic OneFile
![Effects of liraglutide (GLP-1 receptor agonist) – Efficacy and Adverse... | Download Scientific Diagram Effects of liraglutide (GLP-1 receptor agonist) – Efficacy and Adverse... | Download Scientific Diagram](https://www.researchgate.net/publication/309891199/figure/fig1/AS:430371398524929@1479619945957/Effects-of-liraglutide-GLP-1-receptor-agonist-Efficacy-and-Adverse-Effects.png)
Effects of liraglutide (GLP-1 receptor agonist) – Efficacy and Adverse... | Download Scientific Diagram
![The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways | Scientific Reports The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep26859/MediaObjects/41598_2016_Article_BFsrep26859_Fig7_HTML.jpg)
The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways | Scientific Reports
![Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram](https://www.researchgate.net/profile/Iqbal-Malik/publication/23304097/figure/fig2/AS:310188415438849@1450966089391/Mechanism-of-action-of-sitagliptin-vildagliptin-and-exenatide-GLP-1-is-released-from-L.png)
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
![Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus | Arteriosclerosis, Thrombosis, and Vascular Biology Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/776d2592-e059-448c-95fa-daecb07699a9/2198ga1.jpg)
Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus | Arteriosclerosis, Thrombosis, and Vascular Biology
![Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice - Li - 2015 - Journal of Neurochemistry - Wiley Online Library Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice - Li - 2015 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0eabe2b4-f6e8-4719-8acf-a5e94b4a626f/jnc13169-toc-0001-m.jpg)
Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice - Li - 2015 - Journal of Neurochemistry - Wiley Online Library
![Effective Switch From Twice-Daily Pre-Mixed Insulin 50/50 to Liraglutide to Achieve a Good Glycemic Control in Type 2 Diabetes | Yanai | Journal of Medical Cases Effective Switch From Twice-Daily Pre-Mixed Insulin 50/50 to Liraglutide to Achieve a Good Glycemic Control in Type 2 Diabetes | Yanai | Journal of Medical Cases](https://www.journalmc.org/tables/jmc143w-g005.jpg)
Effective Switch From Twice-Daily Pre-Mixed Insulin 50/50 to Liraglutide to Achieve a Good Glycemic Control in Type 2 Diabetes | Yanai | Journal of Medical Cases
![Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists in: Journal of Endocrinology Volume 236 Issue 1 (2018) Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists in: Journal of Endocrinology Volume 236 Issue 1 (2018)](https://joe.bioscientifica.com/view/journals/joe/236/1/images/JOE-17-0278fig1.jpeg)